High Mobility Group Box 1 in Preterm Infants with Intraventricular Hemorrhage

Area of Science:

• Neonatal Medicine
• Biochemistry
• Pediatric Neurology

Background:

• Intraventricular hemorrhage (IVH) is a significant concern in preterm infants, often leading to adverse neurological outcomes.
• High mobility group box 1 (HMGB1) is a protein known to be involved in inflammatory and cellular processes.
• The role of HMGB1 in the pathogenesis of neonatal brain injury, specifically IVH, requires further elucidation.

Purpose of the Study:

• To investigate the association between cord blood levels of high mobility group box 1 (HMGB1) and the presence of intraventricular hemorrhage (IVH) in preterm infants.

Main Methods:

• Cord blood samples were collected from preterm infants at birth.
• Concentrations of HMGB1 were quantified using enzyme-linked immunosorbent assay (ELISA).
• Infants were categorized into two groups: those with diagnosed IVH and those without IVH.

Main Results:

• The concentration of HMGB1 in cord blood was significantly elevated in preterm infants with IVH compared to those without IVH (P=0.041).
• This statistically significant difference indicates a potential link between higher HMGB1 levels and the occurrence of IVH.

Conclusions:

• Elevated cord blood levels of HMGB1 are associated with intraventricular hemorrhage in preterm infants.
• HMGB1 may serve as a potential biomarker for predicting or understanding the risk of IVH in this vulnerable population.
• Further research is warranted to explore the mechanistic role of HMGB1 in the development of IVH.